QKBGX
Price
$23.64
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
330.95M
RLBAX
Price
$40.64
Change
+$0.10 (+0.25%)
Updated
Jun 2 closing price
Net Assets
278.87B
Interact to see
Advertisement

QKBGX vs RLBAX

Header iconQKBGX vs RLBAX Comparison
Open Charts QKBGX vs RLBAXBanner chart's image
QKBGX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
QKBGX vs. RLBAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QKBGX is a Hold and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 279B vs. QKBGX (331M). QKBGX pays higher dividends than RLBAX: QKBGX (1.35) vs RLBAX (1.14). QKBGX was incepted earlier than RLBAX: QKBGX (19 years) vs RLBAX (24 years). RLBAX (1.32) is less costly to investors than QKBGX (1.05). QKBGX is a more actively managed with annual turnover of: 82.00 vs. RLBAX (50.00). QKBGX has a lower initial minimum investment than RLBAX: QKBGX (0) vs RLBAX (250). RLBAX annual gain was more profitable for investors over the last year : 16.80 vs. QKBGX (8.75). RLBAX return over 5 years is better than : 31.17 vs. QKBGX (12.24).
QKBGXRLBAXQKBGX / RLBAX
Total Expense Ratio1.051.3280%
Annual Report Gross Expense Ratio1.051.3280%
Fund Existence19 years24 years-
Gain YTD6.3919.35468%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets331M279B0%
Annual Yield % from dividends1.351.14118%
Returns for 1 year8.7516.8052%
Returns for 3 years32.4142.2377%
Returns for 5 years12.2431.1739%
Returns for 10 years64.3477.0683%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VGZ2.390.02
+0.84%
Vista Gold Corp
SM32.940.27
+0.83%
SM Energy Company
CUBWU10.85N/A
N/A
Lionheart Holdings
PLSE24.26-0.41
-1.66%
Pulse Biosciences
ATOS4.85-0.26
-5.09%
Atossa Therapeutics Inc.